from Buyonfact., page-67

First 67 Last

Share
Profile

Follow
tutes

3,325 Posts.

691

12/11/18

09:37

Post #: 36466767
Share

Originally posted by BarnArse ↑

Here is what I think will happen. As always do not take my word for it or treat anything I say as anything other than opinion/thinking out loud etc.

Rumours will continue to swirl about takeovers etc. I personally think these are just muddying the waters. Based on what we know now the price should be about $2.80 IMO but if any more skeletons leap out of the closet then this will affect the SP. Then, revenues will continue to decline based on lost FUM and reducing margins. Margins will reduce IMO as the fee revenues from funds management and other areas decline. I also see the bank margins declining as they will have to pay more for funds moving forward. My rough guess at this point (about 12-18 months forward) the dividends will be about $0.12c-$0.15c meaning SP of about $1.50 is realistic.

AMP could get stuck for credit and capital as they can no longer easily raise capital meaning that all business units cannot shore up balance sheets and capital requirements. From there it is easy to see a sell off in pieces or a spin off of some business units. If there are anymore smoking guns or skeletons in closets then who would know? We also have 5 class actions and some criminal prosecutions pending so the above is highly contingent on the outcomes of those issues. I just cannot see this as a turn around business but stranger things have happened in the past so what do I know right?

I must also say that I feel a sense of deep and personal pride that some people on this forum would take anything I say so seriously as to think it would affect the share price. Thank you guys so much for your faith and belief in me. Please note however, that I am just a normal person and nothing I say will affect the share price. Please just do your own research and do not be offended when I post my opinions.

Have a great day and good luck.

Expand

Thanks for the reply.

I personally do not take anything you say so seriously.

I disagree with you on the share price going down to $1.50.. i think all the bad news is already priced in, and we should start to see more of a turnaround when the new CEO starts in a few weeks time.

Let's see what happens.

AMP Price at posting: $2.67 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

This thread is closed.

You may not reply to this discussion at this time.

There are more pages in this discussion • 8 more messages in this thread...

First 67 Last

Add AMP (ASX) to my watchlist

(20min delay)
Last $1.32		Change -0.015(1.13%)		Mkt cap ! $3.355B

Open	High	Low	Value	Volume
$1.33	$1.34	$1.32	$6.576M	4.967M

Buyers (Bids)

No.	Vol.	Price($)
6	104225	$1.32

Sellers (Offers)

Price($)	Vol.	No.
$1.32	13812	1

View Market Depth

No.	Vol.	Price($)
6	104225	1.315
7	242116	1.310
4	80262	1.305
7	65872	1.300
4	30029	1.295

Price($)	Vol.	No.
1.320	13812	1
1.330	88211	6
1.335	86498	4
1.340	127748	14
1.345	210517	5

Last trade - 16.10pm 02/10/2024 (20 minute delay)

AMP (ASX) Chart

from Buyonfact., page-67

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

from Buyonfact., page-67

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News